Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 15,520,000 shares, a decrease of 7.1% from the April 30th total of 16,710,000 shares. Based on an average trading volume of 3,110,000 shares, the short-interest ratio […]
Nicolet Advisory Services LLC purchased a new position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 18,297 shares of the biotechnology company’s stock, valued at approximately $152,000. Several other hedge funds […]
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) will be announcing its earnings results before the market opens on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link. Aurinia Pharmaceuticals (NASDAQ:AUPH – Get […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s share price rose 4.8% on Wednesday . The stock traded as high as $10.74 and last traded at $10.64. Approximately 860,249 shares traded hands during trading, a decline of 75% from the average daily volume of 3,486,144 shares. The stock had previously closed at $10.15. Wall Street […]